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      Embryonic murine neuronal networks cultured on microelectrode arrays were used to 
quantify acute electrophysiological effects of fluoxetine and ethanol. Spontaneously 
active frontal cortex cultures showed highly repeatable, dose-dependent sensitivities to 
both compounds. Cultures began to respond to fluoxetine at 3 µM and were shut off at 
10-16 µM.  EC50s mean ± S.D. for spike and burst rates were 4.1 ± 1.5 µM and 4.5 ± 1.1 
µM (n=14). The fluoxetine inhibition was reversible and without effect on action 
potential wave shapes. Ethanol showed initial inhibition at 20 mM, with spike and burst 
rate EC50s at 52.0 ± 17.4 mM and 56.0 ± 17.0 mM (n=15).  Ethanol concentrations above 
100 -140 mM led to cessation of activity. Although ethanol did not change the shape and 
amplitude of action potentials, unit specific effects were found. The combined application 
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CHAPTER 1    
   INTRODUCTION 
 1.1 Overview of Cultured Neuronal Networks 
      It has been suggested  that  cultured  neuronal  networks can be used as experimental  
platforms for the study of neurotoxicology and drug development (Gross et al., 1997b). 
The cultured neural networks display stable spontaneous and long-term activity that can 
be maintained for several months (Gross and Kowalski, 1991). With high reproducibility 
and sensitivity to neuroactive chemicals, such networks can sense the changes of the in 
vitro environment and test for the following effects: (1) changes in metabolism, (2) 
influence on synaptic mechanisms, (3) alterations in membrane permeability, and (4) 
changes in other mechanisms responsible for spike generation and formation of spike 
patterns (Gross et al., 1997b). 
      The Center for Network Neuroscience (CNNS) at the University of North Texas 
(UNT) was the first entity to demonstrate that neuronal networks, grown on arrays of 
microelectrodes in vitro, were uniquely suited for use as broadband biosensors (Gross et 
al., 1992, 1995, 1997a, b).  Based on pharmacological data, it is apparent that all 
receptors, synapses, and cellular mechanisms responsible for pattern generation in a 
specific CNS tissue are retained and represented in culture (Gramowski et al., 2000; 
Morefield et al., 2000; Keefer et al., 2001 a, b, c).  Consequently, I hypothesize that any 
compound that alters these mechanisms to a level that affects the performance and life 
support of an animal should be reflected in changes in the spontaneous activity of the 
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networks. These changes are considered “cell culture correlate responses” to the altered 
behavioral or life-threatening responses that occur in animals.  Therefore, the networks 
are physiological sensors as they appear to be capable of responding to any compounds, 
in approximately the same concentration range, that could destroy or alter the functions 
of an intact mammalian nervous system.  To validate neuronal network responses in 
culture, two common and frequently used compounds (fluoxetine and ethanol) have been 
investigated and their effects and potency have been compared to in vivo studies.  
 
1.2.   Fluoxetine and the Possible Mechanisms Underlying Its Effects 
       Fluoxetine has several trade names, such as Fontex, Prozac, Fluoxetine ratiopharm, 
Fluoxetine selena, Seroscand. It is used for treating depression, obsessive-compulsive 
disorders, bulimia nervosa, and panic/agoraphobia syndrome. 
       Drugs effective in treating depression mainly act on serotonergic and noradrenergic 
systems. The major fibers of the serotonergic system are in the raphé nuclei of the 
brainstem.  The cells from more caudal nuclei innervate the spinal cord and this pathway 
is involved in response to painful stimuli. The cells from the more rostral nuclei project 
diffusely throughout the brain and this pathway is involved in modulation of the sleep-
waking cycle and mood.  Serotonin deficit can be caused by several things: not enough 
production; not enough receptor sites; unusually rapid degradation or reuptake. Serotonin 
deficiency is correlated with depression (Asberg et al., 1976). There are several key steps 
in serotonin transmission. Vesicles of serotonin molecules are released from the axonal 
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boutons of the presynaptic cells into the synaptic gap. These molecules then bind to 
serotonin receptors on the postsynaptic nerve cell membrane and pass along their 
chemical message.  The actions of serotonin are terminated by reuptake into the 
presynaptic cells. Fluoxetine is a selective inhibitor of this uptake and thus increases the 
concentration of serotonin in synaptic clefts.  The effect of increased serotonin 
concentration includes increase in firing or cessation in firing of postsynaptic cells, 
depending on the receptor types activated (Andrade, 1998).                           
      With long-term efficacy, acceptable side effects, and easy administration, fluoxetine 
has been marketed in more than 90 countries and is used by more than 40 million people 
worldwide. In addition to being a useful antidepressant, fluoxetine has become a tool to 
study the mechanisms of depression (Delgado et al., 1990) and other psychiatric disorders 
(Hudson and Pope, 1990). In order to use this drug more effectively, extensive studies are 
still needed to find the involvement of serotonergic pathway in depression and the 
secondary effects of this drug on central nervous system.  
      The binding of [3H]-fluoxetine is used to investigate 5-HT uptake in brain tissue 
(Wong et al., 1993). Saturable binding in cerebral cortical membranes occurs in the 
concentration range of 0.5-10 nM of [3H]-fluoxetine. Voltage-clamp recordings using 
whole-cell configuration of the patch clamp technique indicates that fluoxetine inhibits 
voltage-activated K+, Ca2+, and Na+ currents in pheochromocytoma cells (Hahn et al., 
1999).  Mukherjee (1998) used radiolabeled 18F-fluoxetine as a radiotracer of fluoxetine 
and showed that 18F-fluoxetine binding to rat brain was mainly subcellular and the total 
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binding in all main areas was uniform. Fluoxetine has high selectivity for the 5-HT 
transporter (Wong et al., 1995) and low affinity for neurotransmitter receptors. Thus, it 
has few side effects at low concentrations. 
         Increasing evidence suggests that the serotonergic system can modulate seizures 
and that fluoxetine may have an anticonvulsant action in animal models. This 
anticonvulsant action is due to an increase of endogenous 5-HT transmission. Fluoxetine 
(3.5 nmol) protected rats from limbic motor seizures evoked focally from area tempestas, 
an epileptogenic site in deep rostral piriform cortex. The 5-HT antagonist partially 
reverses the anticonvulsant action of intranigral fluoxetine, and depletion of endogenous 
5-HT completely abolishes the anticonvulsant action of intranigral fluoxetine. These 
observations suggest that the antiseizure action of fluoxetine in substantia nigra is due to 
an enhancement of synaptic action of 5-HT on multiple 5-HT receptors. Endogenous 5-
HT transmission in substantia nigra therefore is capable of limiting the development and 
propagation of seizure activity generated in limbic circuits (Pasini et al., 1996).  
      In my research, spontaneously active monolayer neuronal networks cultured on 
microelectrode arrays were used to determine the effect of fluoxetine on cultured 
embryonic murine frontal cortex. The major observations included suprathreshold 
electrophysiological changes, reversibility, and irreversibility at different concentrations. 
This research further supports the efforts of this laboratory to use neuronal networks as 
screening platforms for neuropharmacological and neurotoxicological studies. The data 
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obtained also support the earlier suggestions that such networks can be used as tissue-
based biosensors.  
 
1.3 Overview of Ethanol 
      Ethanol (CH3CH2OH, ethyl alcohol) belongs to a group of chemical compounds that   
contain a hydroxyl group (–OH) bonded to a carbon atom. The primary target of ethanol 
is the central nervous system. In human, acute ethanol intoxication causes impaired 
judgment, lower self-control, inappropriate behavior, slurred speech, incoordination, and 
unsteady gait. These changes reflect the influence of ethanol on the brain, especially 
prefrontal area, temporal area and cerebellum. In general, functional changes are dose-
related. Ethanol intoxication is usually defined as a blood alcohol level (BAL) of 0.1 g/dL 
(22 mM). A BAL of 0.05-0.10 g/dL (11-22 mM) causes slight impairment of balance, 
speech, reduced judgment and reasoning. A BAL above 0.5 g/dL (110 mM) leads to 
coma and death. Chronic ethanol abuse produces tolerance, dependence, withdrawal, 
anxiety, and hyperexcitability.  
      Although ethanol is a familiar compound, its molecular and cellular mechanisms are 
still not well understood. The lipid theory of alcohol action was advanced for many years 
(Meyer, 1937; Mullins, 1954). It proposed that the disturbance of membrane lipids by 
alcohol influenced the function of membrane proteins which were involved in modulation 
of neuronal activity. However, much criticism has been directed at this theory based on 
the observation that alcohol did not exert direct effects on lipid bilayer membranes. The 
 5 
studies of neuronal firing revealed that ethanol could influence the spontaneous spike 
firing in the central nervous system. It was reported that the intravenous administration of 
ethanol to rats reduced the firing rates of inferior olivary neurons (Harris and Sinclair, 
1984). Siggins et al. (1987) found that, of spontaneously firing CA1 pyramidal neurons, 
10-350 mM ethanol decreased the firing rates in 50%, had no effect in 29%, generated 
biphasic effect in 12%, and increased firing in 9%.  They also observed that the 
application of 50-200 mM ethanol in hippocampal slices increased firing in 32% of the 
neurons, decreased firing in 24%, had biphasic effect in 32%, and generated no obvious 
effect in 12%. The in vitro study of hippocampal pyramidal cells showed that ethanol 
caused excitatory, inhibitory, biphasic effect, or had no effect on neuronal discharge. The 
effect of ethanol on noradrenergic neurons in locus coeruleus was studied by Pohorecky 
and Brick (1977). It was found that intraperitoneal administration of ethanol decreased 
the spontaneous firing in 62%, increased in 22%, and had no effect in 16% of the cells 
tested. There were also studies on the cellular mechanisms of ethanol effect, such as 
voltage-gated ion channels and ligand-gated ion channels (Aguayo, 1990; Benson et al., 
1989; White et al., 1990).  
      Although many studies have been done on ethanol, the knowledge of the effect of 
ethanol on different brain regions is incomplete (Little, 1999). In this research, the 
response of cultured frontal cortex networks to ethanol has been studied, which sheds 
light on the action of ethanol on frontal cortex.  
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1.4 Objectives of Study 
      The major purpose of this research was to investigate the responses of cultured frontal 
cortex networks to fluoxetine and ethanol and to compare these responses to the results 
obtained in other investigations, especially in vivo studies.  This allows a comparison of 
in vitro dose-response data with responses of organisms and helps substantiate the use of 
cultured networks as pharmacological assay systems and biosensors.  
      Specific aims were to:    
(1) Characterize the electrophysiological effects of fluoxetine on murine embryo 
frontal cortex cultures. 
(2) Examine the electrophysiological effects of ethanol on murine embryo frontal 
cortex cultures. 
(3) Determine the dose-response relationships of fluoxetine and ethanol. 
      (4) Compare the effects to those obtained in brain slices and in vivo studies.   
(5) Determine if both substances together generate additive effects.  
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Cell Culture 
       Dissociated embryonic murine frontal cortical tissues were cultured following 
Ransom (Ransom et al., 1977) with some modification that included the use of DNase to 
dissociate tissue (Gross, 1979; Gross and Kowalski, 1991).  
      To ensure cell adhesion to the insulation material, butane flaming was used to oxidize 
the methyl group of polysiloxane to hydroxyl groups and form a hydrophilic surface 
(Lucas et al., 1986). Flaming through a stainless steel mask produced a central adhesion 
island (3 mm in diameter) centered on a 0.8 × 0.8 mm recording matrix and a separate 
medium conditioning area. Poly-D-lysine and laminin, used for substrate preparation, 
adhered only to the flamed regions. Cortical tissues were obtained from 15-16 day old 
Balb-C/ICR murine embryos. The tissues were dissociated mechanically (mincing and 
triturating) and enzymatically (with DNase). Figure 1 shows the procedures of the cell 
culture performed by the CNNS culture staff.  
            The tissue were seeded onto the prepared areas of the multielectrode arrays 
(MEAs) and maintained in Dulbecco's modified minimal essential medium (DMEM), 
supplemented with 5% horse serum and 5% fetal bovine serum. Approximately 8 × 105 
cells (neurons and glia) in 1 ml aliquot were seeded on each MEA with medium confined 
to a 4 cm2 area by a silicone gasket (Gross and Kowalski, 1991; Gross and Schwalm, 
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1994). Cells were maintained at 37oC in an atmosphere with 10% CO2 and 90% air for a 
week. Thereafter, cells were fed biweekly with DMEM containing 5% horse serum.        
 
 
Figure 1. Major procedures of cell culture (Drawn by Emese Dian) 
1.  Balb-C/ICR mice are mated for 24 hours, fifteen to sixteen days before culturing. 
2. A single pregnant mouse is anesthetized for each batch of cultures, sacrificed by 
cervical dislocation, and dissected under sterile conditions to remove the uterus. 
3. Ten to fourteen embryos are delivered from the uterus and placed in D1SGH medium. 
4. Each fetus is decapitated and has its frontal cortex removed.   
5. Tissue is minced with two sterile scalpel blades. 
6. Minced cortex is triturated in 5 ml DMEM, 5% horse serum, 5% fetal bovine serum, 
2% B27, 8 µg vitamin C/ml (DMEM5/5). 
 
      The central island of the MMEP culture overlaid the recording matrix and typically 
grew into a confluent glial carpet. Neuronal somata generally developed on the top of 
carpet, and axonal processes grew both below and above of glial layer. The cultures 
displayed spontaneous activity in the pattern of random spiking at about 5-7 days. They 
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were considered mature after 3 weeks and remained spontaneously active and 
pharmacologically responsive for more than half a year (Gross and Kowalski, 1991; 




Figure 2.  Fixed and Bodian stained network cultured on a 64-electrode recording matrix. 
Transparent indium-tin oxide conductors are 8 µm wide and terminate in 4 rows and 16 
columns. Right panel shows morphology of multipolar neurons within the network 
(CNNS archives). 
 
2.2 Preparation of Microelectrode Arrays 
      The techniques for microelectrode plate fabrication and preparation have been 
described before (Gross, 1979; Gross and Lucas, 1982; Gross et al., 1985; Gross and 
Kowalski, 1991; Gross, 1994). MEAs consisted of an array of photoetched electrodes. 
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The MEA (5×5 cm) was prepared from 1.2 mm thick indium-tin oxide (ITO) sputtered 
glass (soda line glass with a 100 nm quartz layer, Applied Films Corp., Boulder, CO), 
photoetched,  spin-insulated with polysiloxane resin, cured at high temperature, and 
deinsulated at the electrode tips via a single laser pulse (Gross, 1979). The exposed ITO 
was electroplated with a thin layer of colloidal gold to decrease the interface impedance 
to 1-2 Mohm at 1K Hz (Gross et al., 1985). 
 
2.3 Recording 
      Recording chambers fabricated by the CNNS were used to maintain neural networks 
in a constant bath of recording medium. This design allowed rapid medium changes and 
short-term pharmacological manipulation. The assembly consisted of an aluminum base 
holding the MEA and a stainless steel chamber. Zebra strips (carbon-filled silicone 
elastomere, Fujipoly, Cranford, NJ) were placed between the amplifier circuit board and 
the MEA to ensure electrical contact (Gross and Kowalski, 1991). Figure 3 depicts the 
assembly of an open recording chamber.  
      The extracellular spike activity was recorded with a computer-controlled, 64-channel 
multiamplifier system (Plexon Inc., Dallas, TX). Preamplifiers were placed on the 
microscope stage to both sides of the recording chamber and connected to the MEA. 
Total system gain was mostly set to 10 K with bandpass usually set at 500 Hz to 6 KHz. 
Activity was displayed on oscilloscopes (Tektronix Inc., Beaverton, Oregon). Spike rates 
from active channels were integrated and displayed on an 8-channel Soltec strip chart  
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Figure 3. Assembled chamber on a microscope stage with 32 preamplifiers attaching each 
side. A gas line provides a humidified mixture of 10% CO2 and 90% air. Four power 
resistors heat the chamber to 37oC. The cap, containing a heated ITO cover, provides a 
clear window for light microscopy and confines the proper atmosphere. A stainless steel 
chamber confines the culture medium (CNNS archives). 
 
 
recorder 8K40 (Soltec Corporation, San Fernando, CA) with rectification followed by 
analog integration with a resulting integration constant from 200 ms to 1 s. The amplifier 
ground was connected to the stainless steel chamber holding the culture medium.  
      Cultures used for experiments were at least 21 days in vitro (d.i.v.) and selected to 
show spontaneous activity. Assembled MEAs were placed on a microscope stage and 
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sustained at 37oC. The pH was maintained at 7.4 with a continuous supply (15 ml/min) of 
humidified 10% CO2 and 90% air confined under a special cap. After assembly, 
individual neuronal activity was monitored at each electrode in real time with analog 
amplifier to provide single unit spike information. Spikes were discriminated using the 
Plexon "box" templates. Action potential profiles passing through two "boxes" were 
identified as specific active units. Spikes with high signal-to-noise ratios were usually 
selected. Whole network data were analyzed with burst recognition and analysis 
programs.  
      Wash medium consisted of fresh DMEM and 5% horse serum. Usually, 60 minutes 
were allowed for the activity to stabilize before recording. Reference activity is the 
activity recorded after washing with fresh medium. During the course of experiment, the 
osmolarity and pH were monitored carefully to assure an optimal environment. 
Osmolarity was measured with a vapor pressure osmometer (Wescor Inc., Utah) at the 
beginning of each experiment and thereafter every three hours. The pH was monitored 
with an Accumet Combination Micro Electrode with Calmol reference (Fisher Scientific) 
using only 100 µl sample volumes.  
 
2.4. Data Analyses 
      Real-time spike production was displayed on oscilloscopes. In view of large amount 
of data and ubiquitous feature of spike clusters (bursts), simplification of data acquisition 
and analysis was necessary. Spike integration was a convenient tool that revealed the 
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major modes of network activity via burst patterns. With integration, the integrated burst 
amplitude and duration could be accurately determined. This burst pattern analysis 
provides highly useful information without complex analysis of individual spike data 
(Gross, 1994). 
      Each electrode could monitor more than one unit. For electrodes having only one 
unit, integrated amplitude reported instantaneous spike frequency and area under the 
curve showed the total spike production. The integrated burst profiles were quantified 
with two thresholds. Low threshold (T1) identified the starting point of burst and high 
threshold (T2) determined sufficient size needed for burst analysis (Fig. 4).  
 











Figure 4. Integration of spike data. Burst establishment and quantification were based on 
two thresholds: T1 and T2. T1 determined the beginning and the end of a burst. T2 chose 




       To determine the changes of network activity with time, mean network spike rates 
and burst rates of all channels over the course of whole experiment were plotted. Plots 
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were also used to determine the initial effective concentration and shut-off concentration. 
Other data such as waveform, integrated burst amplitude and burst duration also were 
analyzed. 
 
2.5 Pharmacological Manipulations 
2.5.1 General Procedures 
      Drugs were micropipetted to the culture medium at 12, 3, 6 and 9 o'clock positions 
near the edge of the chamber to obtain an even distribution. To remove the test drug, 
syringes were used to extract the "old" medium and to add fresh wash medium.  
       The applied concentrations ranged from 0.5 to 75 µM for fluoxetine and from 10 to 
180 mM for ethanol. Concentrations were increased sequentially and activity was 
recorded continuously during the experimental episode. Each concentration was 
maintained for at least 30 minutes. The wash medium was added to the chamber 
immediately after the removal of previous medium. Fluoxetine (C17H18F3NO, HCl) and 
Ethanol (CH3CH2OH, 100%, 200 proof) were obtained from Sigma Aldrich, Inc. (St. 
Louis, MO; Milwaukee, WI).  
 
2.5.2 Specific Manipulations for Ethanol Experiments 
      Ethanol is volatile and the CO2 / air flow used to control pH accelerated the change of 
ethanol concentration in the chamber. Therefore, the maintenance and monitoring of 
ethanol concentrations were critical. Ethanol was added to the wash bottle at the same 
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concentration as that of the recording chamber (Fig. 5). Before administering ethanol to 
the recording chamber, the wash bottle with same concentration of ethanol was connected 
to the gas line that supplied CO2 and air mixture. Concentrations of ethanol were 
determined with an alcohol diagnostic kit (Sigma Diagnostics Inc., St Louis, MO).  
        The major steps to determine alcohol concentration included:   
1. Prepare alcohol reagent solution (ARS) 
2. Blank: 3 mL ARS + 10 µL wash medium.  
3. Test: 3mL ARS + 10 µL sample 
4. Incubate 
5. Measure absorbance at wavelength of 340 nm (A340) 
6. Calculate: Alcohol (mmol/L) = A340  × 48.4 
  
 
2.6  Statistical Analyses  
 
     The network mean spike rates and burst rates are binned data (bin size = 60 seconds) 
averaged across the network. Independent t tests were used to test the difference of two 
means. One-way ANOVA followed by Dunnett's multiple range test was used to test the 








Figure 5. A Recording chamber on the microscope stage. The left side of 32 preamplifiers 
and associated cables can be seen. To maintain ethanol concentration, ethanol was added 
to the wash bottle at the same concentration as that in the recording chamber. The gas 






3.1 Normal Spontaneous Activity of Frontal Cortex Networks 
      The ages of tested frontal cortex cultures ranged from 21 to 61 days in vitro. Active 
units were selected with signal-to-noise ratios (SNR) equal to or greater than 2:1. The 
cultures tested had an average electrode yield of 34.4 % (20 channels) with a mean SNR 
of 3. Big signal amplitudes often reached 300 µV and maximum SNR reached 8:1. Figure 
6 shows the real-time display of frontal cortex networks activity on a Plexon display 
window.  The three panels from left to right show: activity of currently selected channel; 
40-second raster plot of multichannel activity (n = 30); spike display of all selected units.  
      Figure 7 displays waveforms of native activity from two units after unit 
discrimination. The large unit measured 300 µV and small unit measured 150 µV. The 
multichannel recording allows real-time monitoring of network activity.      
       Frontal cortex cultures often display spontaneous activity with phasic and tonic 
spiking. Bursting is highly coordinated and ubiquitous over most selected channels. 
Usually, bursts occurred simultaneously over the discriminated units with some 
“random” spiking among several units between bursts. Mean spike and burst rates were 
averaged over the network using 60 seconds as bin. Generally, mean network spike rates 
fell into the range of 200-1200/minute and burst rates ranged from 10/minute to 
50/minute. A typical raster plot of general firing pattern is shown in Figure 8. The 30-
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second panel shows coordinated bursts and some interburst spiking among the 19 
channels. 




Figure 6. Display of real-time activity of frontal cortex networks.  The three panels from 
left to right show: activity of current channel; 40-second raster of multichannel activity; 
spike display of selected units. Note that the current channel has three waveforms that 
could be discriminated. After discrimination, each unit is given its own raster channel.  
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                                                         100 µV                                                           
                                      0.4 ms 
 
Figure 7.  Two panels of waveforms recorded from two units after spike discrimination. 
The waveforms represent digitized action potentials.  
      
 
  
Figure  8.  A raster plot of digitized activity for a 30-second episode. Coordinated activity 
can be seen among 19 channels in the episode. Single lines represent digitized action 






3.2 Effects of Fluoxetine on Cultured Neuronal Networks 
      Fourteen frontal cortex cultures were used for the study of fluoxetine. The ages of 
the cultures ranged from 21 to 58 days in vitro.  Table 1 lists the fluoxetine 
experiments.  
Experiment Age (d.i.v) Max SNR Avg SNR
YX39 07/29/2001 58 34 4 2.5
YX43 08/31/2001 28 44 6 3
YX44 09/07/2001 28 44 5 2.5
YX45 09/14/2001 44 64 3 2.5
YX47 09/28/2001 34 56 8 2.7
YX48 10/04/2001 54 30 4 3
YX51 10/26/2001 29 25 5 3
YX53 11/09/2001 21 52 10 4
YX55 11/16/2001 28 32 3.5 2.5
YX56 12/12/2001 46 50 8 3.5
YX57 12/13/2001 47 13 6 3
YX58 01/14/2002 31 55 8 3
YX59 01/15/2002 26 20 6 3.5
YX60 02/04/2002 30 33 9 4
Mean 36 39 6 3
     Date % Active channels
 
 




      No apparent change of waveform amplitude or shape was observed under exposure 
to fluoxetine. Figure 9 (A) shows the native waveforms and 9 (B) shows the waveforms 
when exposed to 6 µM fluoxetine. The waveforms did not change before activity was 
completely shut off.   
                A 
                                     
              B  
                                                         100µV                                       
                                                                                                           0.4 ms    
  
 
Figure 9. Panels of representative action potential waveforms from the same recorded 
units of frontal cortical culture (A) in native state and (B) under exposure to 6 µM 
fluoxetine for 30 minutes. Fluoxetine did not induce noticeable changes in the 




       It was observed that fluoxetine produced a uniform effect across the units. Figure 
10 shows the rate histograms of 42 units. The horizontal axis represents time and the 
vertical axis represents spike rates. The rate histograms of all units display a diminution 
in response to 8 µM fluoxetine (vertical line). Although all units decreased their spike 
rates, the level activity plateaus after response stability were different.                     
                             

































































































































































































































































     
                                     
Figure 10. The uniform response of discriminated units to fluoxetine. The graph shows 
the evolution of spike rates (Y-axis) over time (X-axis). All of the 42 units had similar 
responses to 8 µM fluoxetine.  
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      Cell toxicity is the inhibition of cell growth or deterioration of cells due to 
excessive concentrations of a particular agent. Abnormal morphology, including multi-
nucleated giant cells, granular appearance, unusual vacuoles, and tattered cell edges, 
indicates cytotoxicity in morphology. Application of fluoxetine did not induce the 
above changes under microscopic observation.  
      Figure 11 displays the typical response of frontal cortex cultures when exposed to 
fluoxetine. The mean spikes/minute and mean bursts/minute averaged across the 30 
channels were plotted against time. The reference activity of this frontal cortex culture 
was stabilized at mean spike rates of 1000/minute and mean burst rates of 27/minute. 
Fluoxetine at 0.5 µM did not produce obvious change in either spiking or bursting. At 6 
µM, the network activity was suppressed to mean spike rates of 400/minute and burst 
rates of 12/minute. When concentration reached 13 µM, fluoxetine inhibited the spike 
rates and burst rates by 80% and 90%, respectively.  Fluoxetine at 16 µM led to total 
stop of spiking and bursting.  
      Figure 12 shows a typical response followed by reversibility of frontal cortex 
cultures to low-concentration fluoxetine. At 3 µM, fluoxetine caused a 30% decrease in 
both spike rates and burst rates from the reference level. At 8 µM, fluoxetine blocked 
75% spike rates and burst rates and 16 µM fluoxetine brought about cessation of 
activity. Two medium changes following exposure to 16 µM resulted in a return in 
 24 
spike rates and burst rates, which was almost identical to the reference activity but 
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Figure 11. Typical response of frontal cortex culture to fluoxetine. At 0.5 µM, fluoxetine  
did not generate obvious effects. At 16 µM, fluoxetine completely stopped the activity. 
NS = number of units used for calculating mean spike rates; NB = number of units for 
calculating mean burst rates.  
 
 
      The inhibition caused by high concentrations of fluoxetine was partially recovered 
(Fig. 13). The network activity was shut off at 30 µM. After two medium changes, 
spiking and bursting were partially revived to 36% and 58% of reference, respectively. 
Neither of them returned to 100% of reference. Fluoxetine at 50 µM was applied to the 
culture and maintained for 90 minutes, which abolished all the activity. Two medium 
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changes led to partial recovery of activity. The spike rates and burst rates were restored to 
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Figure 12. Response of frontal cortex cultures to fluoxetine with demonstration of 
reversibility.  Initial decrease of activity occurred at 3 µM fluoxetine with activity 
being shut off at 16 µM. Two medium changes led to a return of spike rates and burst 
rates with less fluctuation compared to reference level.   
 
 
      Table 2 summarizes the 14 fluoxetine experiments. The percent change of spike and 
burst rates under certain fluoxetine concentrations were listed and the mean and S.D. of 
percent change were calculated. Dose-response curves of the 14 frontal cortex cultures 
based on this table are shown in Figure 14. Figure 14 (A) is dose-response summary 
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using mean spike rates ± S.D. Cessation of spike production occurred at 10-16 µM. 
EC50 is 4.1 ± 1.5 µM. Figure 14 (B) is the dose-response curve of fluoxetine using 
mean burst rates ± S.D.  EC 50 is 4.5 ± 1.1 µM. Fluoxetine at 10-16 µM led to 



































Figure 13.  Fluoxetine suppressed spiking and bursting of frontal cortex cultures. The 
activity was shut off at 30 µM. Medium change following exposure to 30 µM and 50 
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Summary of Fluoxetine Experiments on Frontal Cortex Cultures  
1. Spike Rate Change 
Exp age                       Fluoxetine Concentration  (µM ) 
No (d.i.v) 0.5 1.5 3 4.5 6 8 10 12.5 16 17.5 20 25 30 75
Percent change (%) of spike rate 
YX39 58 -35 -80
YX43 28 0 -30 -65 -80 -90 -100
YX44 28 -15 -40 -50 -55 -100
YX45 44 -15 -40 -60 -70 -75 -90 -100 -100
YX47 34 0 -85 -90
YX48 54 -100 -100
YX51 29 0 0 -75 -100
YX53 21 0 -30 -65 -90 -100 -100
YX55 28 -70 -90 -100 -100 -100
YX56 46 -35 -78 -85 -100 -100
YX57 47 -85 -100 -100
YX58 31 -35 -95 -100 -100
YX59 26 -90 -100 -100
YX60 30 -5
Mean -1.7 -6 -35 -53 -75 -71 -91 -98 -100 -100 -100 -100 -100 -100
SD 2.89 8.22 4.47 13.2 9.13 9.18 5.84 6.12 0 0 0 0 0 0
2 Burst Rate Change 
Exp age                      Fluoxetine Concentration  (µM ) 
No (d.i.v) 0.5 1.5 3 4.5 6 8 10 12.5 16 17.5 20 25 30 75
Percent change (%) of burst rate
YX39 58 -25 -80
YX43 28 6 -20 -55 -75 -90 -100
YX44 28 -10 -30 -50 -50 -100
YX45 44 0 -20 -55 -65 -75 -90 -100 -100
YX47 34 0 -80 -80
YX48 54 -100 -100
YX51 29 0 0 -65 -100
YX53 21 0 -20 -65 -90 -100 -100
YX55 28 -75 -90 -100 -100 -100
YX56 46 -30 -75 -85 -100 -100
YX57 47 -85 -100 -100
YX58 31 -30 -85 -100 -100
YX59 26 -90 -100 -100
YX60 30 -5
Mean -1.7 -0.8 -24 -48 -71 -68 -89 -98 -100 -100 -100 -100 -100 -100
SD 2.89 5.76 4.92 11.9 7.5 11 6.64 6.12 0 0 0 0 0 0
Table 2. Summary of fluoxetine effect on 14 frontal cortex cultures.  
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Figure 14. (A). Dose-response summary for fluoxetine using network spike rates. 
Cessation of spike production occurred at 10-16 µM. EC50 mean ± S.D. was 4.1 ± 1.5 
µM. (B). Dose response summary of 14 frontal cortex cultures using burst rates. 
Cessation occurred at 10-16 µM. The EC50 was 4.5 ± 1.1 µM.  * indicates the initial 
concentration that causes statistically significant change from control period, P < 0.05, 
one way ANOVA with post hoc Dunnett's test.  
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      Figure 15 shows dose-response curves from five individual frontal cortex cultures. 
This is another way to calculate a population EC50.  From the five individual curves, 
the resulting EC50 was 4.1 ± 0.3 µM. This method shows the inter-culture variability. 
 



































Figure 15. The summary of dose-response curves from 5 individual cultures using spike 
rate data. The EC50 of each curve is shown in the table. With this analysis, EC50 mean 
± S.D. was 4.1 ± 0.3 µM.         
  
       
      The dose-dependent inhibition of burst rates caused by fluoxetine was also 
associated with burst pattern changes. The integrated burst amplitude reflects spike 
frequency in the burst and increases with higher frequencies. It was observed that 
integrated burst amplitude decreased simultaneously with burst rates. However, burst 
amplitude changed at a slower rate compared to burst rates. The burst rates and burst 
amplitude relationship is shown in Figure 16. Native burst rates and burst amplitude 
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were used as reference (100%). Fluoxetine at 0.5 µM did not produce an obvious 
change in either burst rates or burst amplitude.  Fluoxetine at 4.5 µM caused 53 ± 8% 
inhibition in burst rates with 28 ± 10% inhibition in burst amplitude. Fluoxetine at  12.5 
µM led to 98 ± 6% change in burst rates. However, it led to only a 46 ± 8% change in 
burst amplitude (Fig. 16). This suggests that burst initiation is affected more by 
fluoxetine than the character of the burst, i.e., spikes and spike frequency in bursts, 











0 0.5 3 4.5 10 12.5












Figure 16. Summary of burst rates - burst amplitude relationship from 7 cultures. Burst 
rates had a more rapid change compared to burst amplitude (vertical bar represented 





      The relationship between burst rates and burst duration in response to fluoxetine is 
displayed in Figure 17. When applied at 0.5 µM, fluoxetine did not produce significant 
change. At 3 µM, it caused 25 ± 6% decrease in burst rates and 58 ± 6% decrease in burst 
duration. Application of fluoxetine at 12.5 µM caused 96 ± 10% inhibitions in burst 



















Figure 17. The relationship of burst rates and burst duration in response to fluoxetine. 
When applied at 0.5 µM, fluoxetine did not produce significant change. Application of 
12.5 µM fluoxetine caused burst rates to decrease to 4 ± 10% of reference and burst 








3.3 Responses of Cultured Frontal Cortex Networks to Ethanol 
      The control of ethanol concentration is difficult because ethanol is highly volatile. 
In addition, the cultures were under continuous CO2 / air flow to maintain pH, which 
sped up the change of ethanol concentration in medium. To maintain ethanol 
concentrations, ethanol was put into the wash bottle and ethanol concentrations were 
monitored with a diagnostic kit.  Figure 18 shows the results of ethanol concentration 
measurements. The ethanol concentrations in medium changed at a much slower rate 


























Figure 18. The measurements of ethanol concentrations in the culture medium. The data 
show percent change of concentrations against time without (black column) and with 
(gray column) ethanol in the wash bottle. Results represented mean ± S.D. from 6 
separate experiments. * indicates statistically significant difference of the results without 
and with ethanol in the wash bottle after the same time periods (independent student's t 
test, p < 0.05) 
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      Table 3 is a list of the 15 experiments included in the study of ethanol. The ages of 
the cultures ranged from 21 days to 61 days in vitro. 
Experiment Age (d.i.v) Max SNR Avg SNR
Yx15 11/27/2000 30 25 3 2.5
YX16 12/18/2000 31 19 4 2.5
YX17 01/11/2001 21 20 6 3
YX18 01/18/2001 21 25 5 3.5
YX20 02/18/2001 46 24 5 3
YX21 02/26/2001 53 26 10 3.5
YX22 03/04/2001 61 32 5 3
YX25 03/31/2001 22 23 5 3
YX27 04/15/2001 40 33 5 2.5
YX28 04/22/2001 22 41 7 3
YX29 04/29/2001 30 22 3 2.5
YX30 06/03/2001 33 35 6 3.5
YX31 06/10/2001 50 22 8 3.5
YX34 6/31/2001 42 31 8 3.5
Mean 36 27 6 3
     Date % Active channels
 
Table 3. List of frontal cortex cultures used in the study of ethanol. (d.i.v = days in 
vitro; SNR = signal-to-noise ratio) 
 
                  
      Ethanol did not cause major change in action potential shape. Figure 19 depicts 
digitized action potential (waveform). Panel (A) shows the native waveforms of three 
units.  Panel (B) shows the waveforms of the same units under 40 mM ethanol.  No major 
waveform changes were found.  
      Ethanol inhibited the spiking and bursting in a dose-related way. Figure 20 is the rate 
histograms of 36 units from one culture. The spike rates of each unit were plotted against 
time.  Among the 36 units, 40 mM ethanol decreased firing in 70%, increased firing in 
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16%, and generated no effect in 14%. The major effect was a reduction in activity. For all 
the ethanol experiments, 40 mM ethanol decreased firing in 71%, increased firing in 
20%, and generated no effect in 9% (total unit numbers were 200). Consequently, unit-
specific effects were observed. 
                 A.  
                                           
 
      B.  
                                    100µV         
                                                                                                         
                                                                                                     0.4 ms 
 
Figure 19.   Panel (A) shows the native waveforms of three units.   Panel (B) shows the 
waveform of the same units under exposure to 40 mM ethanol.  The waveforms did not 
show major changes.  
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Figure 20. Responses to ethanol across the recorded units in one network. Among the 36 
units, 40 mM ethanol (vertical line) decreased firing in 70%, increased firing in 16%, and 
generated no effect in 14%. The major effect was a reduction in activity. 
 
 
      Figure 21 shows typical activity change in response to ethanol. Activity decreased 
upon application of 20 mM ethanol. Progressive decrease in spiking and bursting 
occurred at increasing ethanol concentrations. Ethanol at 100 mM caused immediate 
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Figure 21. Effect of ethanol on a frontal cortex culture. A decrease occurred in spiking 
and bursting upon addition of 20 mM ethanol with progressive reduction with 
increasing concentrations. 100 mM ethanol shut off all the activity.  
 
 
      The inhibition caused by ethanol was reversible. Figure 22 shows that the activity 
returned following a medium change after exposure to 160 mM ethanol. Despite 
immediate 100% suppression of network activity, the network was restored to close-to-
native spike and burst rates. Following the presence of 180 mM ethanol, only 25% 




































Figure 22.  Reversibility of frontal cortex networks in response to ethanol. Ethanol at 
160 mM caused total cessation of spiking and bursting. A complete medium change 
revived spike and burst rates to close-to-native state. After exposure to 180 mM ethanol 
for 20 minutes, a medium change caused only partial recovery of spiking and bursting 
to 25% and 60% of baseline, respectively.  
 
      
      Table 4 summarizes the responses of 15 frontal cortex cultures to ethanol. The 
percent change of spike rates and burst rates under the influence of ethanol was shown 










Summary of Ethanol Experiments on Frontal Cortex Cultures  
1. Spike Rate Change 
Exp Age Concentration  (mM ) 
No (d.i.v) 10 20 40 60 80 100 120 140 180
Percent change (%) of spike rate 
YX15 30 -40 -60 -90
YX16 31 5 -30 -50 -55 -50
YX17 20 -25 -60 -69 -83 -100 -100
YX18 20 -8 -15 -50 -53 -70 -100
YX20 46 -60 -95
YX21 53 -30 -40 -50 -85 -100
YX22 61 -50 -65 -90
YX25 22 -67 -60 -100
YX26 30 -100
YX27 40 -95 -100
YX28 22 -100 -100
YX29 30 -80 -85 -90 -100
YX30 33 -54 -90 -100
YX31 50 -100 -100
YX34 42 -60
Mean -1.5 -25 -52.86 -57.57 -64.71 -92 -95 -100 -100
SD 9.19 7.07 7.53 10.2 13.38 7.58 4.63 0 0
2. Burst Rate Change 
Exp Age Concentration  (mM ) 
No (d.i.v) 10 20 40 60 80 100 120 140 180
Percent change (%) of burst rate 
YX15 30 -45 -58 -85
YX16 31 0 -30 -60 -62 -65
YX17 20 -10 -30 -48 -60 -100 -100
YX18 20 -10 -20 -45 -55 -70 -100
YX20 46 -65 -90
YX21 53 -10 -40 -55 -83 -100
YX22 61 -50 -60 -90
YX25 22 -63 -70 -100
YX26 30 -100
YX27 40 -95 -100
YX28 22 -100 -100
YX29 30 -74 -90 -90 -100
YX30 33 -65 -90 -100
YX31 50 -100 -100
YX34 42 -70
Mean -5 -17.5 -48.33 -56.86 -57.45 -91.6 -94.38 -100 -100
SD 7.07 9.58 12.91 7.78 7.12 8.08 4.64 0 0
    Table 4. Summary of 15 frontal cortex cultures in response to ethanol.  
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       The ethanol dose-response curves using spike rates and burst rates based on table 4 
are shown in Figure 23 (A) and (B).  EC50s for spike and burst rates were 52.0 ± 17.4 
mM and 56.0 ± 17.0 mM, respectively. In the presence of higher concentrations, the 
network activity was further decreased. 100-140 mM ethanol stopped both spiking and 
bursting in all networks.   
      Figure 24 shows the dose-response curves from four individual cultures using spike 
rates. The dose-response curves were obtained from each network separately. This is 
another way to get the EC50, which also shows the inter-culture variability. The 
resulting EC50 for spike rates is 48.8 ± 13.8 mM.  
       The relationship between burst rates and burst amplitude was important in 
identifying network response to certain compounds. Ethanol reduced burst amplitude 
by 10 ± 7%, 12 ± 12% and 15 ± 9% at concentrations of 40, 80 and 100 mM, 
respectively. In presence of the same concentrations, there was a greater dose-
dependent inhibition on burst rates that averaged at 45 ± 9%, 57 ± 9%, and 83 ± 6%, 
respectively (Fig. 25). 
       The relationship between burst rates and burst duration is depicted in Figure 26. 
Ethanol led to concentration dependent inhibition of burst duration. Ethanol at 40 mM 
caused a 45 ± 9% decrease in burst rates and a 61 ± 9% decrease in burst duration. 
























































Figure 23. Dose-dependent response to ethanol using (A) spike rates and (B) burst 
rates. The curves summarized data from 15 experiments. Vertical bar represented mean 
and S.D. of activity change. EC50s were 52.0 ± 17.4 mM and 56.0 ± 17.0 mM for spike 
and burst rates, respectively. Concentrations above 100-140 mM led to cessation of 
spiking and bursting.  *  indicates the initial concentration that causes significant 
































Figure 24. The summary of dose-response curves of 4 frontal cortex cultures. EC50s of 
each curve are given in the table. This is another way to calculate EC50 mean ± S.D. 
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Figure 25. The relationship between burst rates and burst amplitude in response to 
increasing concentrations of ethanol. Ethanol caused a rapid change in burst rates. 
Raising ethanol caused burst amplitude to progressively decrease, but at a lower rate.  



















Figure 26. The relationship between burst rates and burst duration under exposure to 
ethanol. 40 mM ethanol caused a 45 ± 9% decrease in burst rates and a 61 ± 9% 
decrease in burst duration.  Further decrease in burst duration was not observed before 




3.5 The Combination Effect of Fluoxetine and Ethanol  
 
      The combination effect of fluoxetine and ethanol on frontal cortex culture also was 
studied in this research. The ages of the cultures ranged from 30 to 45 days in vitro.  
Table 5 lists the experiments on the study of combination effects.  
       Neither amplitude nor shape of the action potential (waveform) was altered by co-
application of fluoxetine and ethanol. Figure 27 displays the native waveforms (panel A) 
and the waveforms under the co-application of 5 µM fluoxetine and 20 mM ethanol 




    Exp No Date Age(d.i.v)   % active channels Max SNR  Avg SNR  
 
YX62 03/10/2002 30 43  9 3.5  
YX63  03/16/2002 36 23  8 3.5  
YX64 03/19/2002 45 30  7 4  
YX65 03/23/2002 43 30  7 3  
   
Table 5. Summary of the experiments on combination effect of fluoxetine and ethanol. 
d.i.v = days in vitro; SNR = signal-to-noise ratio.  
 
 
      Figure 28 displays the typical response of frontal cortex culture under exposure to 
fluoxetine and ethanol. The baseline spike and burst rates were 420/minute and 
23/minute, respectively. Ethanol was maintained at 20 mM and fluoxetine concentrations 
were increased sequentially. Under 1 µM fluoxetine, the spiking decreased to 82% of 
baseline and bursting showed minor change. Under 5 µM fluoxetine, the spike rates 
decreased to 30% of baseline and burst rates dropped to 35% of baseline. When 
fluoxetine was increased to 10 µM, both spiking and bursting were stopped. Two medium 
changes partially revived the activity.        
      The combination application of fluoxetine and ethanol caused greater inhibition than 
the effect caused by fluoxetine or ethanol when applied alone. However, synergistic 
effects were not observed.  Figure 29 is the dose response curves of fluoxetine + ethanol 
(dash curves) and fluoxetine only (solid curves).  The combination application shifted the 
curves to the left, which implies an additive effect. 
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                         A. 
                                      
                       B. 
                                                                   100 µV 
                                                                                                                 0.4 ms         
 
 
Figure 27. Panel (A) illustrates the native waveforms of three channels. Panel (B) 
exhibits the waveforms of the same channels when exposed to 5 µM fluoxetine and 20 
mM ethanol. No major change in amplitude or shape was evident.   
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Figure 28. The combination effect of fluoxetine and ethanol on frontal cortex culture. 
Ethanol was maintained at 20 mM and fluoxetine concentrations were increased 
sequentially. Both spiking and bursting were stopped when fluoxetine was increased to 







































Exp No EC50 (µM) Exp No EC50 (µM)
YX 64 2.7 YX 44 4.3
YX 65 2.4 YX 53 4.4
YX 56 3.8
Mean 2.6 Mean 4.2




Figure 29. The comparison of dose-response curves of fluoxetine + 20 mM ethanol (dash 
curves, YX64 & YX65) and fluoxetine only (solid curves, YX 44,YX53 & YX56). The 
combination use shifts the curves to left and demonstrates greater inhibition than that 
caused by fluoxetine alone. The above table compares the EC50s from the experiments 





4.1 Effects of Fluoxetine on Frontal Cortex Cultures 
      Fluoxetine, a specific serotoinin reuptake inhibitor (SSRI), first appeared in the 
scientific literature in the 1974 issue of Life Sciences (Wong et al., 1974). It is referred to 
as a breakthrough in treating depression. 
       The serotonergic system is implicated in numerous behaviors and physiological 
functions, such as emotion, sleep, cognition and appetite. Decreased serotonergic 
neurotransmission plays an important role in the etiology of depression. The reuptake of 
serotonin into the pre-synaptic terminal via transporter is one pathway to terminate 5-HT 
action. Fluoxetine, with a high selectivity for 5-HT transporter, binds to 5-HT uptake 
sites in brain tissue (Wong et al., 1995) and thus modulates serotonin concentration in 
synapses. 
      There are more than 14 serotonin receptor types distributed over 7 distinctive 
receptors subfamilies (Andrade, 1998). Cortical neurons typically show a mixed 
inhibitory and excitatory response to 5-HT, which reflects the dual actions at 5-HT2/1C 
and 5-HT1A receptors expressed by the same neurons. The direct action of 5-HT at the 
cellular level has a complicated effect. While 5-HT1A agonist inhibits the serotonergic 
neurons in raphe nuclei, this inhibition may be the mixed effect of disinhibition for 
postsynaptic neurons that express 5-HT1A receptors and disfacilitation for postsynaptic 
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neurons that express 5-HT2, 5-HT3, and 5-HT4 receptors. Similarly, while 5-HT2 agonist 
may directly excite a subpopulation of GABAergic interneurons in the cerebral cortex 
that express 5-HT2 receptors, this excitation may be the mixed effect of inhibition for 
those pyramidal cells that receive input from these interneurons. Thus, functional 
consequence of the discrete cellular actions of 5-HT is closely related to the structure of 
neuronal networks (Aghajanian et al., 1990) 
      The clinical optimal dose range of fluoxetine is 20-40 mg/day and the therapeutic 
plasma concentration is 1 µM (Altamura et al., 1994). However, fluoxetine is lipid 
soluble with high brain-to-blood ratio ranging from 10 to 20 (Tsuneizumi et al., 1992; 
Karson et al., 1993) and the concentration in brain can be as high as 20 µM. However, 
fluoxetine is able to penetrate cell membranes and may distribute in intracellular 
components, so the concentration in synapses may be lower. An autoradiographic study 
with 18F-fluoxetine showed that total binding in various brain areas such as frontal cortex, 
thalamus, hypothalamus, striata, cerebellum and olfactory tubercle was generally uniform 
(Mukherjee et al., 1998). The therapeutic brain concentration of 10 to 20 µM fluoxetine 
was close to the range used in my study.  In my research, the effect of fluoxetine on the 
cultured cortical networks was tested, primarily to validate the neuronal network as a 
histiotypic system. When applied at 0.5 µM, fluoxetine did not produce obvious effects 
and the initially effective concentration was 3 µM.  EC 50 for spike rates was 4.1 ± 1.5 
µM and EC50 for burst rates was 4.5 ± 1.1 µM.  Both spiking and bursting were 
abolished at 10-16 µM (Fig. 14 A and B). 
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       Consistent with my observation that high concentration of fluoxetine arrested all the 
activity, it was reported that fluoxetine overdoses were fatal. One study reported that, 
among 633 adult patients who overdosed on fluoxetine hydrochloride alone, 34 resulted 
in a fatal outcome and 15 patients experienced different neurological and cardiovascular 
sequelea. The most common signs and symptoms associated with non-fatal overdosage 
were seizures, somnolence, nausea, tachycardia, and vomiting (website, 
http://www.rxlist.com/cgi/generic3/prozac_weekly_od.htm).  Borys et al. (1992) reported 
324 cases of fluoxetine overdose (232-1390 ng/mL, 0.67- 4.01 µM). Common symptoms 
included tachycardia, sedation, tremor, nausea, and emesis. 
      The elimination half-life of fluoxetine is 1-3 days after a single dose and 4 days after 
long-term administration. It is metabolized to the active metabolite norfluoxetine, which 
is also a specific serotonin reuptake inhibitor with an average elimination half-life of 7 
days after long-term administration (Sommi et al., 1987). It is generally thought that a 
delay of 2-3 weeks is necessary before an antidepressant produces any improvement in 
the symptomatology of depressive patients. The delay is associated to the time needed to 
arrive at appropriate concentrations at target region and to regulate the monoaminergic 
system (down-regulation process). A study among 943 depressive patients, given 20 mg 
fluoxetine once a day, showed that the frequency distribution of the delay of an initial 
improvement mentioned by patients was bimodal with peaks at 5 and 11 days of 
treatment (Mesters et al., 1995). However, serotonin reuptake inhibitors rapidly block 
uptake sites or transporters, and cause neurochemical changes immediately.  Thus, the 
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clinical efficacy cannot be entirely explained by direct blockade of 5-HT transporters. 
Other long-term changes should be taken into consideration (Hebert et al., 2001). 
       The data in this research showed that fluoxetine had an inhibitory effect on frontal 
cortex in the range of 3 to 16 µM. Along with the change in burst rates, the integrated 
burst amplitude and burst duration also showed dose-related diminution (Fig. 16 and Fig. 
17). All these data suggested that fluoxetine may have anti-convulsant effects. It has been 
observed that enhancement of serotonin in brain exerts significant anticonvulsant effects 
on generalized epilepsy (Torre et al., 1970; Buterbaugh, 1978; Dailey et al., 1992; 1996; 
Prendiville and Gale, 1993). Reduced serotonin level showed proconvulsant effect 
(Kilian And Frey, 1973; Statnick et al., 1996).  The anticonvulsant effects of serotonin 
reuptake inhibitors have been indicated in a variety of experimental models. Co-
administration of fluoxetine and anticonvulsants enhanced the anticonvulsant effect in 
mice. A clinic study reported seizure occurrence after sudden stop of fluoxetine (Epelde 
et al., 1999). The antiseizure effect was found to be dependent on brain serotonin (Yan et 
al., 1994b; Pasini et al., 1996). Wada et al. (1999) found that concomitant administration 
of fluoxetine and 5-HT1A receptor antagonist produced a significant increase in the 
threshold of focal hippocampal seizures in rats and thus decreased seizure. The inhibitory 
effect was abolished by pre-depleting brain 5-HT. Lu et al. (1998) documented that field 
excitatory postsynaptic potential and epileptiform activity were reversibly depressed by 
serotonin in the rat hippocampus. The studies supported that increased 5-HT 
neurotransmission in the hippocampus can inhibit seizures and the anticonvulsant action 
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of fluoxetine is due to increasing level of endogenous serotonin. Yan et al. (1994a) found 
that fluoxetine (intraperitoneal injection) diminished the audiogenic seizure intensity in 
genetically epilepsy-prone rats and proposed that a serotonergic mechanism was involved 
in the antiseizure effect of fluoxetine. Two exploratory experiments included in this 
research showed that application of 1-300 µM serotonin decreased both spike rates and 
burst rates (data not shown). However, it did not even reduce the network activity by 
30%. The data suggested that the other mechanisms might be involved in the cessation of 
activity after application of fluoxetine.  
      Exposure to fluoxetine did not produce apparent change in waveform amplitude or 
shape (Fig. 9).  Neural spike change was a reflection of alteration in membrane 
potential as a function of time. The consistency of waveform suggests that low-
concentration fluoxetine does not affect the Na+ or K+ channels that are involved in 
action potential generation. However, it is interesting to note that fluoxetine shuts off 
all spiking in the network. Such a shut-off is not seen with botulinum toxin or tetanus 
toxin. This implies that fluoxetine may have secondary effects on spike generation at 
high concentrations.  
      In addition to its actions on the well-known action on serotonin reuptake system, 
fluoxetine has a variety of other effects. Garcia-Colunga et al. (1997) reported that 
neuronal nicotinic acetylcholine receptors were blocked by fluoxetine in a 
noncompetitive and voltage-dependent way. Nicotinic receptors are widely distributed in 
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the central nervous system, and thus the blocking action of fluoxetine on nicotinic 
receptors may play an important role in the antidepressant and other therapeutical effects. 
 
4.2 Effects of Ethanol on Frontal Cortex Cultures 
      Among all the organ systems affected by ethanol, the central nervous system 
manifests the most obvious effect with immediate motor and emotional changes. The 
actions of ethanol are very complex and the mechanisms are not well understood.  
      The data in this study showed that acute exposure to ethanol decreased activity of 
frontal cortex cultures. The tested doses ranged from 10 mM to 180 mM. EC 50s were 
52.0 ± 17.4 mM for spike rates and 56.0 ± 17.0 mM for burst rates. At concentrations as 
high as 100-140 mM, ethanol abolished both spiking and bursting (Fig. 23). Ethanol 
caused minor change in burst amplitude and major decrease in burst duration (Fig. 25 and 
26). The action potential (waveform) did not change under the influence of ethanol (Fig. 
19). It is interesting to note that wash after application of 180 mM ethanol caused only 
partial recovery. It is not certain if cell death has occurred and further studies may 
provide explanation on this issue.  
        This dose-dependent effect of ethanol was consistent with previous studies which 
addressed the association of blood concentrations of ethanol with certain behavioral 
effects. In mice, 40 mM led to a lack of righting reflex and 122 mM led to sleep and 
hyothermia (Little,  1990). In rats, 20 mM ethanol caused sedation. In human, 5-15 mM 
ethanol caused slight impaired attention, judgment and coordination, loss of efficiency in 
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fine performance, and minor euphoria. Ethanol at 15-30 mM resulted in significant 
sedation, ataxia, and confusion (Charness et al., 1989). Ethanol at 30-55 mM induced 
total mental confusion. Concentration at 50-100 mM led to loss of consciousness and 
central depression. Coma and respiratory arrest occurred when concentration reached 
above 100 mM. Ethanol consumption leads to change in psychomotor performance. It 
was reported that 0.1g/100dL BAL ethanol (22 mM) was associated with a 10% slowing 
of reaction time, increased errors and an increase in serious road accidents (Borkenstein, 
1964; Robertson and Drummer, 1994). All these observations were made in the 
concentration range of 10-100 mM that was effective in cell cultures.  
      The effects of ethanol on neuronal firing were proposed in some studies. Benson et al. 
(1989) reported that 50-100 mM ethanol suppressed the firing of CA1 pyramidal 
neuronal in hippocampal slices. This effect was not attributed to changes of either 
membrane potential or membrane conductance. It was observed that ethanol 
(intraperitoneal injection, 1-4g/kg, blood concentration around 27-108 mM) caused a 
decrease in the spontaneous activity of Purkinje cells (Sorensen at al., 1981). Givens and 
Breese (1990) observed that ethanol (intraperitoneal injection, 0.75-3.0 g/kg, blood 
concentration around 20-80 mM) reduced neural firing of medial septal cells in a dose-
dependent fashion and ethanol disrupted the rhythmic bursting pattern of medial septal 
neurons. Grupp (1980) observed that low concentration of ethanol caused an increase in 
the neuronal firing frequency or an excitatory effect followed by some reduction in firing 
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rates. Increasing concentrations produced augmented inhibition in firing. The changes in 
unit firing appeared to be correlated with the pattern of fronto-cortical EEG activity.  
      Some studies suggested that ethanol disrupts synaptic transmission in cerebral cortex 
and reduces or abolishes evoked patterns of activity. Chapin and Woodward  (1983) 
reported that ethanol inhibited selective gating of somatosensory input to cortical 
neurons. Gruol (1982) found that, in cultured spinal cord neurons, ethanol caused a 
reduction in spontaneous activity at concentration as low as 20-30 mM. The rates of 
spontaneous EPSPs and IPSPs displayed major changes. However, the amplitude of these 
potentials remained the same. It was possible that ethanol influenced the firing of 
presynaptic neurons but not the synaptic transmission. The data in my research also 
supported that ethanol did not change the shape or amplitude of action potential before 
the total cessation of activity.  
      It was reported that acute exposure to ethanol caused enhanced GABAA receptor 
function (Chandler et al., 1998; Nishio and Narahashi, 1990; Reynolds and Prasad, 1991; 
Soldo et al., 1998; Tatebayashi et al., 1998). Lovinger et al. (1989;1990) studied the 
effect of ethanol on glutamate-activated channels in cultured murine hippocampal 
neurons with patch-clamp technique. Ethanol significantly decreased the amplitude of 
NMDA-activated current at the concentration ranges of 5-50 mM with IC50 at 30 mM. 
Application of ethanol at intoxicating concentrations on cultured murine cortex and 
spinal cord neurons showed similar effect. Increasing concentrations of ethanol caused 
increasing suppression of NMDA receptor-mediated EPSPs within concentration ranges 
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of 1-50 mM. These observations suggested that the inhibition of NMDA 
receptor/ionophore complex might contribute to acute ethanol intoxication. At low doses, 
ethanol produced euphoria and anxiolytic effect. The euphoric effect could be related to 
endogenous opiate and dopamine system. 
       There also have been a number of studies on the effect of ethanol on inhibitory 
transmitter-γ-aminobutyric acid (GABA), which generated different results. It is still 
uncertain whether ethanol potentiates GABA-mediated transmission or not. Procter et al. 
(1992) reported ethanol potentiated GABAA receptor-mediated EPSP in cerebral cortex. 
The effects of ethanol on the GABAA-stimulated Cl- current were potentiated in cultured 
mouse hippocampal, spinal and cortical neurons (Aguayo and Pancetti, 1994).  Ethanol at 
10-50 mM elicited a dose-related potentiation of GABA-mediated Cl- flux in the cultured 
spinal cord neurons (Allan and Harris, 1986; Suzdak et al., 1988).  However, some 
studies failed to see the potential effect of ethanol on GABA. It was reported that ethanol 
(10-200 mM) did not produce any effect on hippocampal neurons (Gage and Robertson, 
1985).  
 
4.3 Combination Effect of Fluoxetine and Ethanol  
 
      It is suggested that individuals taking fluoxetine should avoid ethanol during the 
course of treatment because ethanol may increase the sedative effects of fluoxetine. 
Although fluoxetine is generally thought to have a good safety in overdose, very high 
dose can cause serious side effects, such as seizures, electrocardiogram (ECG) changes, 
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and decreased consciousness. This toxicity is usually increased while taking ethanol 
simultaneously. Several fatalities due to combined use of fluoxetine and ethanol have 
been reported. Barbey and Roose (1998) reported that SSRI overdoses in combination 
with ethanol intake led to increased toxicity.  Although it is cautioned that ethanol intake 
should be restricted during fluoxetine medication, only a very limited number of studies 
exist on the combination effect of the two compounds. The data in my research show that 
co-administration of fluoxetine and 20 mM ethanol shifted the dose-response curves to 
the left, which implies an additive effect (Fig. 29). Based on the ethanol data, 20 mM 
ethanol is not highly effective and reduced the network activity slightly. Consequently, 
the combination use of fluoxetine and ethanol produced more inhibitory effect. This 
research provided more evidence that ethanol should be restricted while on fluoxetine 
medication.  
 
4.4 Application of Neuronal Networks 
       During drug development and pharmacological evaluation, an efficient and reliable 
experimental platform is needed before studies involve animal experiments. Neurons, 
with intrinsic electrophysiological mechanisms, can be utilized to detect ligand-receptor 
interactions, alteration in ion channels and membranes, and neurotoxicity. The cultured 
neuronal networks grown on microelectrode arrays show high sensitivity to the medium 
environment and provide rapid monitoring of this environment. The multi-unit recording 
of cultured neuronal networks is a valuable advance with many advantages, which 
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includes better control of compound concentrations, real-time monitoring of activity 
changes, and long-term experiments.  Network mean spike and burst rates are the primary 
and simple parameters to study network activity. Many other features, such as integrated 
burst amplitude and burst duration, are also important in data analyses. 
       The cultures used in this research had different ages, seeding dates, cell densities, 
percentage of active channels and signal-to-noise ratios. The control of experimental 
environment, such as pH, osmolarity and temperature, is critical to reduce the 
intracultural and intercultural variability. However, small fluctuations are unavoidable 
and contribute to the variability of network responses. Errors resulting from drug mixing 
and concentration calculation also added to experimental variability. A higher stability of 
neuronal network could have been achieved if the experimental variables that may affect 
neuronal responses could be limited. Before improvement can be made, numerous studies 
have to be conducted to demonstrate that networks in culture are pharmacologically 
histiotypic. This research has contributed to this important effort.  
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